STING1 and cancer: Despite extensive efforts to develop deliverysystems and materialscapable of activating the STING pathway for cancer immunotherapy,significant challenges remain.49−52 Our study presents an injectable SF hydrogel-basedin situ vaccine for cancer immunotherapy.